Inspirata announces a multi-year extension of its relationship with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
Category: Press & Media
Inspirata looks forward to celebrating the 25th annual National Cancer Registrars Week (NCRW) during the week of April 5th, 2021.
Sign up to receive Press & Media updates
Proposed FDA Regulatory Flexibilities Permit Primary Diagnosis with Inspirata’s Dynamyx Digital Pathology Solution
Regulatory flexibilities issued by the FDA may enable Inspirata’s digital pathology solution, Dynamyx, to be used for primary diagnosis in perpetuity, without the need for 510(k) premarket notification.
Tampa, Florida, January 7, 2021 / GlobeNewswire – Cancer informatics and digital pathology provider Inspirata announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent
Experienced Healthcare Leader Stephen Keresztes, MD, MBA Joins Inspirata as Head of Oncology Informatics
Tampa, Florida, December 3, 2020 / GlobeNewswire – Inspirata announced today the appointment of Dr. Stephen Keresztes to the company’s leadership team. Effective December 1st, 2020, Dr. Keresztes serves
Inspirata and Smart Reporting Announce New Technical Partnership and Integration at Pathology Visions 2020
The new technical partnership between Inspirata and Smart Reporting endeavors to add structured reporting to case management within the Dynamyx Digital Pathology software suite. Tampa, FL / Munich,
Inspirata and Flagship Biosciences Announce New Technical Partnership and Integration at Pathology Visions 2020
The new technical partnership between Inspirata and Flagship Biosciences provides clinicians with a seamless, fully automated AI send-out solution, offering significant advantages over standard material transfers. Tampa, FL